IN-VIVO EVALUATION OF SPRAY FORMULATIONS OF HUMAN INSULIN FOR NASAL DELIVERY

被引:40
作者
DONDETI, P [1 ]
ZIA, HS [1 ]
NEEDHAM, TE [1 ]
机构
[1] UNIV RHODE ISL,COLL PHARM,DEPT PHARMACEUT,KINGSTON,RI 02881
关键词
INSULIN; HUMAN; NASAL ADMINISTRATION; SPRAY FORMULATION; BIOADHESIVE POLYMER; MICROCRYSTALLINE CELLULOSE; PLASTOID; AMMONIUM GLYCYRRHIZINATE; GLYCYRRHETINIC ACID; SODIUM TAUROCHOLATE;
D O I
10.1016/0378-5173(95)00045-K
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There are many ongoing investigations to improve the nasal bioavailability of peptide and protein formulations. The presence of bioadhesive polymers in nasal formulations may increase the residence time of the drugs in the nasal cavity. A combination of bioadhesive polymers with permeation enhancers would seem to further improve nasal bioavailability. In this study, insulin spray formulations containing two bioadhesive polymers (1.5% w/v microcrystalline cellulose (MCC) and 70% w/w Plastoid L50) alone or in combination with the enhancers such as sodium taurocholate (ST), ammonium glycyrrhizinate (AG) or glycyrrhetinic acid (GA) at 1% w/v level, were evaluated in diabetic rabbits. A total volume of 100 mu l of freshly prepared insulin formulation was sprayed into the nasal cavity of each diabetic rabbit. Glucose levels were monitored using a blood glucose assay and serum insulin levels were analyzed using RIA. 5 U/kg insulin in the MCC suspension alone resulted in an absolute bioavailability of 1.96% while Plastoid L50 alone resulted in 2.25% absolute bioavailability. Insulin in the MCC suspension and ST, AG or GA resulted in 8.36, 7.83 and 2.15% bioavailability, respectively. The same formulations produced a hypoglycemic effect in terms of total glucose reductions of 39.12, 15.96 and 9.36% and the maximal decreases in glucose levels were 58.37, 21.8 and 18.61%, respectively. The Plastoid formulation containing 1% ST provided nasal insulin bioavailability of 5.9% with a total glucose reduction of 17.03% and a maximal glucose decrease of 26.56%. Insulin spray formulations containing 1% ST alone and 1% AG alone resulted in bioavailabilities of 7.25 and 3.57%, respectively. These same sprays provided total glucose reductions of 25.08 and 16.97% with maximal glucose decreases of 44.56 and 19.81%, respectively. The presence of benzalkonium chloride and 2-phenylethanol as preservatives in the MCC suspension resulted in higher insulin absorption than the same formulation without preservatives (6.31% vs 1.96%).
引用
收藏
页码:91 / 105
页数:15
相关论文
共 50 条
  • [31] IN-VITRO AND IN-VIVO ANALYSIS OF COLON SPECIFICITY OF CALCIUM PECTINATE FORMULATIONS
    RUBINSTEIN, A
    RADAI, R
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1995, 41 (05) : 291 - 295
  • [32] In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery
    Sonaje, Kiran
    Lin, Yu-Hsin
    Juang, Jyuhn-Huarng
    Wey, Shiaw-Pyng
    Chen, Chiung-Tong
    Sung, Hsing-Wen
    BIOMATERIALS, 2009, 30 (12) : 2329 - 2339
  • [33] In Vitro Cell Culture Evaluation and In Vivo Efficacy of Amphiphilic Chitosan for Oral Insulin Delivery
    Shelma, R.
    Sharma, Chandra P.
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2013, 9 (02) : 167 - 176
  • [34] Vesicular Emulgel Based System for Transdermal Delivery of Insulin: Factorial Design and in Vivo Evaluation
    Shehata, Tamer M.
    Nair, Anroop B.
    Al-Dhubiab, Bandar E.
    Shah, Jigar
    Jacob, Shery
    Alhaider, Ibrahim A.
    Attimarad, Mahesh
    Elsewedy, Heba S.
    Ibrahim, Mahmoud M.
    APPLIED SCIENCES-BASEL, 2020, 10 (15):
  • [35] In vivo evaluation of biochemical efficacy of prepared insulin-loaded nanoliposomes for oral delivery
    Gharib, Amir
    Faezizadeh, Zohreh
    CLINICAL BIOCHEMISTRY, 2011, 44 (13) : S218 - S218
  • [36] In vivo evaluation of physiological efficacy of insulin-loaded nanoliposomes prepared for oral delivery
    Gharib, Amir
    Faezizadeh, Zohreh
    PHYSIOLOGY AND PHARMACOLOGY, 2011, 15 (01): : 57 - 65
  • [37] In vitro and in vivo evaluation of an oral multiple-unit formulation for colonic delivery of insulin
    Maroni, Alessandra
    Del Curto, Maria Dorly
    Salmaso, Stefano
    Zema, Lucia
    Melocchi, Alice
    Caliceti, Paolo
    Gazzaniga, Andrea
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2016, 108 : 76 - 82
  • [38] Recent Advances in Inhaled Formulations and Pulmonary Insulin Delivery Systems
    Liu, Haofan
    Shan, Xiaosong
    Yu, Jiaojiao
    Li, Xin
    Hu, Liandong
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2020, 21 (03) : 180 - 193
  • [39] Microencapsulation techniques to develop formulations of insulin for oral delivery: a review
    Cardenas-Bailon, Fernando
    Osorio-Revilla, Guillermo
    Gallardo-Velazquez, Tzayhri
    JOURNAL OF MICROENCAPSULATION, 2013, 30 (05) : 409 - 424
  • [40] Insulin-Loaded Microcapsules for In Vivo Delivery
    Kim, Byung Soo
    Oh, Jae Min
    Hyun, Hoon
    Kim, Kyung Sook
    Lee, Sang Hyo
    Kim, Yu Han
    Park, Kinam
    Lee, Hai Bang
    Kim, Moon Suk
    MOLECULAR PHARMACEUTICS, 2009, 6 (02) : 353 - 365